← Back to Episodes
PODCAST

When Menopause Gets Dark: Suicidality, Bone Clues & a Big New Study

August 21, 2026·10:15·Episode 107

Quick Summary

This episode covers a qualitative study on how fragmented care systems fail women experiencing suicidality during menopause, a promising new blood marker for detecting bone thinning early, and the launch of one of the most detailed long-term menopause studies ever designed. Friday format — research grounded, lighter in places, and worth your weekend thinking.

When Menopause Gets Dark: Suicidality, Bone Clues & a Big New Study

0:000:00

Key Takeaways

  • A 2026 qualitative study found that clinicians and caregivers consistently identified fragmented, siloed care as a key failure point when menopausal women reached a mental health crisis — menopause and mental health services often don't talk to each other.
  • Suicidality during perimenopause and menopause is real and documented, but it remains dramatically undertreated and under-recognized in primary care.
  • Xylosyltransferase-I (XT-I) is a blood enzyme that may signal bone thinning earlier than current standard tests — still early-stage research, but worth watching.
  • The KiSO-DP cohort study will track women through the full menopausal transition using biological, psychological, and lifestyle data collected from the same participants over time — the kind of within-person design that produces much more reliable answers than snapshot studies.
  • Research on menopause is getting more ambitious and more rigorous — and the questions being asked are finally catching up to what women have been reporting for decades.

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.